A multi-omic integrative scheme characterizes tissues of action at loci associated with type 2 diabetes
Jason TorresiD, Moustafa AbdallaiD, Anthony Payne, Juan J. Fernandez-TajesiD, Matthias ThurneriD, Vibe NylanderiD, Anna L. GloyniD, Anubha MahajaniD, Mark I. McCarthyiD
Abstract
Resolving the molecular processes that mediate genetic risk remains a challenge as most disease-associated variants are non-coding and functional and bioinformatic characterization of these signals requires knowledge of the specific tissues and cell-types in which they operate. To address this challenge, we developed a framework for integrating tissue-specific gene expression and epigenomic maps (primarily from tissues involved in insulin secretion and action) to obtain tissue-of-action (TOA) scores for each association signal by systematically partitioning posterior probabilities from Bayesian fine-mapping. We applied this scheme to credible set variants for 380 association signals from a recent GWAS meta-analysis of type 2 diabetes (T2D) in Europeans. The resulting tissue profiles underscored a predominant role for pancreatic islets and, to a lesser extent, subcutaneous adipose and liver, that was largely attributable to enhancer elements and transcribed regions, particularly among signals with greater fine-mapping resolution. We incorporated resulting TOA scores into a rule-based classifier, and validated the tissue assignments through comparison with data from cis-eQTL enrichment, functional fine-mapping, RNA co-expression, and patterns of physiological association. In addition to implicating signals with a single tissue-of-action, we also found evidence for signals with shared effects in multiple tissues as well as distinct tissue profiles between independent signals within heterogeneous loci. Lastly, we demonstrated that TOA scores can be directly coupled with eQTL colocalization to further resolve effector transcripts at T2D signals. This framework guides mechanistic inference by directing functional validation studies to the most relevant tissues and can gain power as fine-mapping resolution and cell-specific annotations become richer. This method is generalizable to all complex traits with relevant annotation data and is made available as an R package.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 36
- FWCI
- 3.22
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ancestry-specific TWAS refines type 2 diabetes GWAS loci in disease-relevant tissues
Inti Pagnuco, Stephen Eyre, … Andrew P. Morris·medRxiv·Aug 22, 2026
- Integrative cross tissue analysis of gene expression identifies novel type 2 diabetes genes
Jason Torres, Alvaro Barbeira, … Hae Kyung Im·bioRxiv·Feb 27, 2017
- Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtypes
Miriam S. Udler, Jaegil Kim, … José C. Florez·bioRxiv·May 11, 2018
- High-throughput Genetic Clustering of Type 2 Diabetes Loci Reveals Heterogeneous Mechanistic Pathways of Metabolic Disease
Hyunkyung Kim, Kenneth E. Westerman, … Miriam S. Udler·DiabetologiaPeer-reviewed·Dec 20, 2022
- Influence of genetic variants on gene expression in human pancreatic islets - implications for type 2 diabetes
Ana Viñuela, Arushi Varshney, … Mark I. McCarthy·Nature CommunicationsPeer-reviewed·Sep 30, 2020
- Multi-omics characterization of type 2 diabetes associated genetic variation.
Ravi Mandla, Kimberly Lorenz, … Josep Maria Mercader·medRxiv·Jul 15, 2024